Figure 6.

Changes in QoL over time. (A) Normed subscale and component scores from the SF-36 survey, with higher scores indicating greater health-related QoL. Differences in scores between baseline and the latest time point that meet or exceed MIDs are illustrated with a delta symbol (Δ) followed by the value of the difference. The dotted line indicates the general US population average. (B) All patients and patients with low SF-36 scores (<45) at baseline with clinically relevant changes in SF-36 scores at their last visit. The bottom table shows responder analysis of patients with low SF-36 scores at baseline. (C and D) (C) Mean patient and (D) physician global assessment scores are shown, with lower scores indicating a reduction in disease activity. n values in C and D are 37 and 32, respectively. Baseline was defined as the start of either the DFT or RCT. If a patient had a treatment gap >42 days between the DFT or RCT and the OLE, or they did not participate in either trial. ED 1 values were used as baseline. Error bars are SD. BP, bodily pain; CFB, change from baseline; GH, general health; MH, mental health; MID, minimally important difference; PF, physical functioning; PGA, physician global assessment; PtGA, patient global assessment; QoL, quality of life; RCT, randomized controlled trial; RE, role (emotional); RP, role (physical); SF, social functioning; VT, vitality.